Medtronic CoreValve Evolut R U.S. Clinical Study

NACompletedINTERVENTIONAL
Enrollment

241

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

August 31, 2015

Study Completion Date

October 28, 2020

Conditions
Aortic Stenosis
Interventions
DEVICE

CoreValve Evolut R TAVR system

Trial Locations (23)

10016

New York Langone Medical Center, New York

10029

The Mount Sinai Medical Center, New York

10032

Columbia University Medical Center, New York

11576

St. Francis Hospital, Roslyn

15213

University of Pittsburg Medical Center, Pittsburgh

17043

Pinnacle Health, Wormleysburg

20010

Washington Hospital Center/Medstar, Washington D.C.

21287

The Johns Hopkins University, Baltimore

27710

Duke University Medical Center, Durham

43214

Riverside Methodist Hospital/Ohio Health Research Institute, Columbus

46290

St. Vincent Heart Center of Indiana/The Care Group, LLC, Indianapolis

48109

University of Michigan Health Systems, Ann Arbor

48201

Detroit Medical Center Cardiovascular Institute, Detroit

49503

Spectrum Health, Grand Rapids

53215

Aurora Health Care/St Luke's Medical Center, Milwaukee

66160

University of Kansas, Kansas City

75225

Baylor Heart and Vascular Hospital, Dallas

77030

The Methodist DeBakey Heart & Vasc Ctr/The Methodist Hosp, Houston

85006

Banner Good Samaritan Medical Center, Phoenix

90033

University of Southern California, Los Angeles

06520

Yale New Haven Hospital, New Haven

02215

Beth Israel Deaconcess Medical Center, Boston

07962

Morristown Memorial Hospital, Morristown

Sponsors
All Listed Sponsors
lead

Medtronic Cardiovascular

INDUSTRY